Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAPIDE - TKM for Ebola
PACTR201501000997429Completed
- Sponsor
- University of Oxford
- Start
- Feb 2015
- Modality
- Gene Therapies, Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of TKM-100802 in Ebola virus disease (EVD), sponsored by University of Oxford. Started Feb 2015; status: completed.
02
Drugs
TKM-100802
03
Conditions
Ebola virus disease (EVD)
Beyond the preview
Go deeper on PACTR201501000997429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201501000997429.